Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity
June 30, 2021 at 07:00 AM EDT
LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that Dr. Serhat Gumrukçu, co-founder and inventor of Enochian BioSciences and Director of Seraph Research Institute (SRI), presented data demonstrating daily reduction of Hepatitis B Virus (HBV) until it could no longer be detected by the 8th day. No toxicities to the liver or other tissues were identified. The findings were presented during the prestigious International Liver Conference, and presentations can be found (Link to presentations.)
Enochian BioSciences holds the exclusive license for the proprietary technology. The daily measurements, studies of various doses of the product, and toxicity are important components for review by regulatory agencies.
The innovative cellular therapy, known as Hijack RNA, tricks the viruses to use proteins that are needed to reproduce, in order to trigger the infected cells to commit suicide instead of becoming a virus-making factory. On June 21, Enochian BioSciences announced the acquisition of an exclusive license for the use of the Hijack RNA approach as a potential way to treat or prevent any variant of influenza or coronaviruses, including the one that causes COVID-19 (see news release). A similar approach to potentially treat or cure HIV is being developed to expand Hijack RNA as an Enochian BioSciences platform to treat deadly viruses.
Dr. Mark Dybul, a public health expert in HIV and Executive Vice Chairperson of the Board of Enochian BioSciences commented, “The promising data presented by Dr. Gumrukçu builds on growing evidence that this novel strategy could potentially cure HBV, a condition which affects approximately 350 million individuals worldwide. Combined with the promising results from studies to treat or prevent any coronavirus or influenza virus, the data also offers hope that Hijack RNA could be a powerful platform technology to combat some of the most devastating diseases in the world.”
About Enochian BioSciences, Inc.
About Seraph Research Institute (SRI)